Autopsy report · NCT00722254

Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder

“This study was stopped due to poor enrollment numbers”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 1 month after it had already started.
• Ran for about 2 years 8 months before it stopped.
• 15 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

University of Utah

Sponsor type

University, hospital or other

Conditions

Primary Myelofibrosis; Primary Pulmonary Hypertension; Secondary Myelofibrosis; Pulmonary Arterial Hypertension

Participants

15

Sites

2

Countries

United States

Trials that died the same way

• The Role of Osteopathic Manipulative Medicine in Recovery From Concussions
  “Due to lower than anticipated enrollment number, this study was stopped.” (87% match in meaning)
• Hand Injected Ventriculography vs. Power Injected Left Ventriculography
  “Study was stopped due to low enrollment.” (87% match in meaning)
• Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
  “The study was halted because enrollment was too slow” (85% match in meaning)
• Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
  “The study was discontinued early due to lack of funding and slow enrollment” (84% match in meaning)
• Salvage Cryotherapy in Recurrent Prostate Cancer
  “Study was ended due to low enrollment” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.